Yuen Chi Ho
Appearances
- DateMay 18, 2024BACKGROUND: While sodium-glucose cotransporter 2 inhibitors improves cardiovascular and renal outcomes irrespective of diabetes mellitus (DM) status, their effects in metabolic-dysfunction associated steatotic liver disease (MASLD) patients without diabetes mellitus (DM) are unknown…
Presenter
Speakers
University of Hong Kong Li Ka Shing Faculty of Medicine
